Trial
NCT05714553
NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
NuCana plc
Collaborators
—
Condition
Advanced Cancer
Intervention
Fosifloxuridine Nafalbenamide
Why stopped
The NuTide:303 study was terminated at NuCana's discretion following refinement of the NUC-3373 development strategy.
Provenance
Dataset: 2026-07-24 • Source: ClinicalTrials.gov API v2 • Last update: 2026-07-23